4575, doi.org/10.3390/jcm12144575
Yes, in fact it is probably more beneficial to older individuals
However, we can hypothesize that if a significant amount of LNC ends up in the liver, and the components of the formulation do contribute to ameliorating the disease, further combined with their effect on GLP-1 secretion, this could explain the significant effect observed in liver inflammation and immune cell infiltration
Recommended approach for first-time users: Week 1: SS-31 only, 5mg/day subQ Weeks 25: SS-31 (510mg/day) + MOTS-C (500mcg daily or 1mg EOD) Week 6+: Continue both or assess what's driving results and adjust --- Running This Stack Alongside Semaglutide or Reta GLP-1 agonists (semaglutide, tirzepatide, retatrutide) already improve metabolic efficiency by reducing caloric intake, improving insulin sensitivity, and decreasing systemic inflammation
Using untested raw materials
10.1016/j.metabol.2024.156043 [DOI] [PubMed] [Google Scholar] Loomba R., Abdelmalek M